Geron Corporation
Clinical trials sponsored by Geron Corporation, explained in plain language.
A biopharmaceutical company developing therapies for hematologic malignancies.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New drug may free MDS patients from frequent blood transfusions
Disease control OngoingThis study tests a drug called imetelstat in adults with a bone marrow disorder (MDS) who currently need regular red blood cell transfusions because standard treatments have stopped working. The main goal is to see if the drug can help patients go 8 weeks or more without a transf…
Phase: PHASE2, PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for myelofibrosis patients who fail current treatments
Disease control OngoingThis phase 3 trial tests a drug called imetelstat against the best available treatments for people with advanced myelofibrosis whose disease has stopped responding to JAK inhibitors. The study includes 327 participants and aims to see if imetelstat can help them live longer and f…
Phase: PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC